Abstract
The molecular mechanism of iron transfer across placenta in response to maternal anemic status/ iron supplementation is not clear. We hypothesized that maternal iron/ anemia status during early trimesters can be utilized as a biomarker tool to get estimates of placental iron status. Early interventions can be envisaged to maintain optimum placental/ foetal iron levels for healthy pregnancy outcomes. One hundred twenty primigravida were recruited and divided into non-anemic and anemic group on the basis of hemoglobin levels. The groups were randomly allocated to receive daily and weekly iron folic acid (IFA) tablets till six weeks postpartum. Hematological and iron status markers in blood and placenta were studied along with the delivery notes. Weekly IFA supplementation in anemic primigravidas resulted in significantly reduced levels of hematological markers (p < 0.01); whereas non-anemic primigravidas showed lower ferritin and iron levels, and higher soluble transferrin receptor levels (p < 0.05). At baseline, C-reactive protein and cortisol hormone levels were also significantly lower in non-anemic primigravidas (p < 0.05). A significantly decreased placental ferritin expression (p < 0.05); and an increased placental transferrin expression was seen in anemic primigravidas supplemented with weekly IFA tablets. A significant positive correlation was observed between serum and placental ferritin expression in anemic pregnant women (r = 0.80; p < 0.007). Infant weight, gestational length and placental weight were comparable in both the supplementation groups. To conclude, mother’s serum iron / anemia status switches the modulation in placental iron transporter expression for delivering the optimum iron to the foetus for healthy pregnancy outcomes.
Trial Registration
Clinical Trial Registry-India: CTRI/2014/10/005135.
Similar content being viewed by others
References
De Benoist B, McLean E, Egli I, Cogswell M. Worldwide prevalence of anaemia 1993–2005. In: WHO Global Database on Anaemia. World Health Organization. 2008. http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf. Accessed 26 July 2013.
Milman N. Oral iron prophylaxis in pregnancy: not too little and not too much! J Pregnancy. 2012. https://doi.org/10.1155/2012/514345.
Widdowson EM, Spray CM. Chemical development in utero. Arch Dis Child. 1951;26:205–14.
Li Y-Q, Yan H, Bai B. Change in iron transporter expression in human term placenta with different maternal iron status. Eur J Obstet Gynecol Reprod Biol. 2008;140:48–54.
Orberger G, Fuchs H, Geyer R, Gessner R, Köttgen E, Tauber R. Structural and functional stability of the mature transferrin receptor from human placenta. Arch Biochem Biophys. 2001;386:79–88.
Georgieff MK, Wobken JK, Welle J, Burdo JR, Connor JR. Identification and localization of divalent metal transporter-1 (DMT-1) in term human placenta. Placenta. 2000;21:799–804.
Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000;403:776–81.
Kroos MJ, Starreveld JS, Verrijt CE, van Eijk HG, van Dijk JP. Regulation of transferrin receptor synthesis by human cytotrophoblast cells in culture. Eur J Obstet Gynecol Reprod Biol. 1996;65:231–4.
Verrijt CE, Kroos MJ, Huijskes-Heins MI, Cleton-Soeteman MI, van Run PR, van Eijk HG, et al. Accumulation and release of iron in polarly and non-polarly cultured trophoblast cells isolated from human term placentas. Eur J Obstet Gynecol Reprod Biol. 1999;86:73–81.
Young MF, Pressman E, Foehr ML, McNanley T, Cooper E, Guillet R, et al. Impact of maternal and neonatal iron status on placental transferrin receptor expression in pregnant adolescents. Placenta. 2010;31:1010–4.
Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 2005;1:191–200.
Langini SH, de Portela ML, Lázzari A, Ortega Soler CR, Lönnerdal B. Do indicators of maternal iron status reflect placental iron status at delivery? J Trace Elem Med Biol. 2006;19:243–9.
Gambling L, Danzeisen R, Gair S, Lea RG, Charania Z, Solanky N, et al. Effect of iron deficiency on placental transfer of iron and expression of iron transport proteins in vivo and in vitro. Biochem J. 2001;356:883–9.
McArdle HJ, Morgan EH. Transferrin and iron movements in the rat conceptus during gestation. J Reprod Fertil. 1982;66:529–36.
Li Y, Yan H, Bai B, Zhang Q. Effect of iron status of pregnant women on ferroportin 1 expression in third-trimester placenta. Wei Sheng Yan Jiu. 2008;37:335–8.
Kumar N, Gupta N, Kishor J. Kuppuswamy’s socioeconomic scale: updating income ranges for the year 2012. Indian J Public Health. 2012;56:103–4.
Shankar H, Kumar N, Sandhir R, Mittal S, Kurra S, Dhaliwal L, et al. Weekly iron folic acid supplementation plays differential role in maintaining iron markers level in non-anaemic and anaemic primigravida: a randomized controlled study. Saudi J Biol Sci. 2016;23:724–30.
Cetin I, Berti C, Mandò C, Parisi F. Placental iron transport and maternal absorption. Ann Nutr Metab. 2011;59:55–8.
Bradley J, Leibold EA, Harris ZL, Wobken JD, Clarke S, Zumbrennen KB, et al. Influence of gestational age and fetal iron status on IRP activity and iron transporter protein expression in third-trimester human placenta. Am J Physiol Regul Integr Comp Physiol. 2004;287:R894–901.
Bastin J, Drakesmith H, Rees M, Sargent I, Townsend A. Localisation of proteins of iron metabolism in the human placenta and liver. Br J Haematol. 2006;134:532–43.
Acknowledgements
The authors are highly thankful to Mr. Santosh Kurra and Dr. Mohd. Tarique from Biochemistry department and Dr. Sandeep Mathur from Pathology department, AIIMS for their inputs in carrying out immunohistochemistry work. The authors also wish to acknowledge continuous support provided by Dr. Rohini Sehgal, Dr. Arun Kumar, Mrs. Leema Maithi and Mrs. Shobha Kandpal from HRRC, AIIMS for enrolment and follow-up of the patients.
Funding
This study was funded by Indian Council of Medical Research, New Delhi, India (grant no. 5/7/165/06-RHN and 5/7/304/08-RHN).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Research Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethics approval was obtained from the Institute Ethics Committee of All India Institute of Medical Sciences, New Delhi, India.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Shankar, H., Kumar, N., Sandhir, R. et al. Differential Iron Status and Trafficking in Blood and Placenta of Anemic and Non-anemic Primigravida Supplemented with Daily and Weekly Iron Folic Acid Tablets. Ind J Clin Biochem 35, 43–53 (2020). https://doi.org/10.1007/s12291-018-0794-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-018-0794-2